Dyadic International, Inc. (DYAI) Financials

DYAI Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 9.3 million 1.6 million
2023-06-30 11.1 million 2.1 million
2023-03-31 12.8 million 2.0 million
2022-12-31 13.7 million 2.6 million

DYAI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.0 million 281307
2023-06-30 -1.7 million 334316
2023-03-31 -2.2 million 330639
2022-12-31 -1.7 million 480734

DYAI Net Income

No data available :(

DYAI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 8.2 million - 148166
2023-06-30 10.1 million - -
2023-03-31 11.7 million - -
2022-12-31 12.6 million - -

DYAI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 28.8 million
2023-06-30 28.8 million
2023-03-31 28.8 million
2022-12-31 28.4 million

DYAI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 716351 1.3 million -
2023-06-30 - 917552 1.4 million -
2023-03-31 - 810566 1.5 million -
2022-12-31 - 584120 1.7 million -

DYAI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 397060 105869
2023-06-30 837159 792944
2023-03-31 978052 726918
2022-12-31 743726 704491

DYAI

Price: $1.43

52 week price:
1.19
2.40

Earnings Per Share: -0.23 USD

P/E Ratio: -6

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 58579

Market Capitalization: 52.4 million

Links: